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ABSTRACT
TheE2F1transcriptionfactorisanessentialmediator
of p53-dependent and p53-independent apoptosis
as part of an anti-tumour safeguard mechanism. In
this study, a functional so-called technical knockout
(TKO) approach was applied to Saos-2ERE2F1 cells
that conditionally activate E2F1 by the addition of
4-hydroxytamoxifen to search for p53-independent
pro-apoptotic E2F1 targets. The approach was
basedonrandominactivationofgenesafterretroviral
transfer of an antisense cDNA library enriched
of E2F1-induced genes, followed by the selection of
Saos-2ERE2F1 cells that survive in the presence of
the apoptotic stimulus. We identified 13 novel E2F1
target genes encoding proteins of known cellular
function, including apoptosis and RNA binding.
FACS analysis revealed that E2F1-induced apoptosis
was significantly attenuated in cell clones contain-
ing the antisense cDNA fragments of these genes,
demonstrating their participation in E2F1 death path-
ways. Moreover, inactivation of the target genes
resulted in a clear increase of cell viability (>80%) in
response to E2F1 activation compared with controls
( 30%). Four genes showed an increase in expres-
sion intensity in the presence of cycloheximide, sug-
gesting a direct effect of E2F1 on gene transcription,
whereas one gene was identified as an indirect tar-
get. Our data provide new insight in the regulation
of E2F1-induced apoptosis.
INTRODUCTION
E2F is a transcription factor family that modulates cellular
proliferation, differentiation and apoptosis of eukaryotic
cells (1–4). It functions as heterodimers with members of
the DP family (DP-1 and DP-2). E2F1 transcriptional activity
is modulated at multiple levels, including negative regulation
by association with the RB tumour suppressor gene product
and its related proteins p107 and p130 (5). The interaction
between E2F1 and RB is limited by Rb phosphorylation,
which is mediated by the cyclin D/cyclin-dependent kinase-
4 at the G1/S transition point, thus releasing E2F1 and lead-
ing to cell cycle progression (1,5,6). In response to genotoxic
stress, E2F1 is stabilized by distinct mechanisms, including
direct phosphorylation through the ataxia–telangiectasia
mutated (ATM) kinase, the ATM and RAD3-related (ATR)
kinase and the Chk2 kinase (7–9), and also by acetylation
through p300/CREB-binding protein associated factor
(P/CAF) (10).
Amongseven E2Ffamilymembersidentiﬁedsofar,E2F1is
unique in that it efﬁciently regulates both cellular proliferation
and apoptosis. Several recent reports have emphasized that
apoptosis induction by E2F1 activation can be both dependent
and independent of p53. In the p53-dependent pathway, over-
expression of E2F1 induces p53 stabilization and accumula-
tion (3,11), e.g. through direct transactivation of p14ARF/
p19ARF tumour suppressor genes (12,13). In the absence of
ARF (14–16), E2F1 uses the ATM signalling pathway to
induce p53 and Chk2 phosphorylation and thereby apoptosis
(9). In the p53-independent pathway, a variety of key
pro-apoptotic genes are directly upregulated by E2F1 activa-
tion, including p73 (17,18), Apaf-1 (19), and BH3-only pro-
teins, PUMA, Noxa, Hrk/DP5 and Bim (20). All of them
contribute to E2F1-induced apoptosis. Nevertheless, the
mechanism by which E2F1 induces apoptosis has not been
fully understood.
One of the ﬁrst function-based gene identiﬁcation systems
in mammalian cells was the so-called technical knockout
(TKO) method, where an antisense cDNA library in an epi-
somally replicating vector (episomal shuttle vector) was intro-
duced into human cells and subsequently the cells were
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doi:10.1093/nar/gki581screened for the loss of response towards a killing signal. It
is assumed that the speciﬁc inactivation of a growth inhibi-
tory gene conveys growth advantage in a speciﬁc restrictive
environment, followed by the selection of phenotypic changes
caused by its inactivation (21). This functional genetic
approach led to the identiﬁcation of several mediators of
IFN-g induced cell death, including cathepsin D protease,
DAP3(death-associatedprotein-3)andanovelserine/threonine
kinase (21–24). As the TKO selection requires the transfection
of large number of cells with one/few transcription units that
express individual antisense cDNAs in the target cells, the
maintenance and isolation of these episomally promoted vec-
torscanbedifﬁculttoachieve.Asretrovirusesaretheonlygene
transfer system that efﬁciently and stably integrates into the
genomic DNA of cells thereby readily allowing single-cell
cloning,wedecidedtoswitchtheTKOapproachtoanoncoret-
roviral expression system for the introduction of an antisense
cDNA library into target cells.
A key element in this approach is a cDNA library, which is
enriched in transcripts of genes involved in p53-independent
E2F1-mediated apoptosis. In the p53-deﬁcient human
osteosarcoma cell line, Saos-2ERE2F1, which constitutively
expresses E2F1 fused to the binding domain of the murine
oestrogen receptor (ER) (25), the addition of 4-hydroxy-
tamoxifen (4-OHT) results in the translocation of E2F1 to
the nucleus where it activates its downstream target genes.
Using this cell system, we previously identiﬁed a number
of genes with different cellular functions that are upregulated
by E2F1 in a cDNA microarray-based analysis (25). This cell
line was utilized here to construct an antisense cDNA library
enriched in E2F1-induced genes in a self-inactivating oncoret-
roviral vector. Following retroviral infection, integrated
antisense cDNA fragments inhibited the expression of
E2F1-related pro-apoptotic genes, resulting in a reduced
susceptibility of the cells to the 4-OHT-induced death signal.
With this approach, we identiﬁed 13 candidate genes with
distinct physiological functions, demonstrating that E2F1-
induced apoptosis is regulated at different levels.
MATERIALS AND METHODS
Cell culture, virus and transfection
Saos-2ERE2F1 cells have been described previously (25).
Cells were maintained in DMEM (Invitrogen, Karlsruhe,
Germany) supplemented with 10% fetal calf serum
(Biochrom, Berlin, Germany) at 37 C and in 5% CO2.
Media for the maintenance of Saos-2 ERE2F1 cells contained
puromycin (Sigma, Steinheim, Germany) at a concentration of
1 mg/ml. E2F1 activity in Saos-2ERE2F1 cells was induced by
1 mM 4-OHT. HEK293T cells were maintained in DMEM
medium. All retroviral supernatants were produced into
Iscove’s Modiﬁed Dulbecco’s Medium containing HEPES
(Sigma). All media were supplemented with 100 mg/ml peni-
cillin and 100 U/ml streptomycin (Invitrogen). The vectors
Ad-GFP and Ad-ERE2F1 have been described previously
(26,27). Adenoviral infection was carried out at multiplicity
of infection (MOI) 35, which allows 100% transduction of
the Saos-2ERE2F1 cell line. Transfection was performed by
electroporation (18).
Preparation of antisense cDNA library andconstruction
of a retrovirus-derived expression plasmid
Saos-2ERE2F1 cells were induced by the addition of 4-OHT
at a ﬁnal concentration of 1 mM. Eight hours after induction,
total RNA was extracted by RNeasy Maxi Kit according to the
manual (Qiagen, Hilden, Germany) and poly(A) mRNA was
isolated by mRNA Oligotex kit (Qiagen). The cDNA library
was constructed mainly based on SUPERSCRIPT  Plasmid
System with GATEWAY  Technology for cDNA Synthesis
and Cloning (Invitrogen). Instead of using pSPORT 1 plasmid
provided with the kit, a self-inactivating oncoretroviral plas-
mid, pCAMS/U3EPac (Figure 1A), was utilized to express the
antisensemRNAtranscripts.Thisplasmidwasoriginatedfrom
the pCAMS/U3E vector which we previously used in a two-
plasmid system to produce GALV-pseudotyped oncoretroviral
vectors (28). For construction of the library, the following
modiﬁcations were made. First, the plasmid backbone was
exchanged to include the oriP from the SV40 virus to improve
virus production in HEK293T cells. Second, the MluI site 50
of the cytomegalovirus promotor was destroyed and
re-introduced between the NotI site and the 30 SIN LTR.
Third, the enhanced green ﬂuorescent protein (EGFP)
sequence 30 of the SFFV promotor was replaced by a linker
(AscI-30sequence of SFFV–PacI–NotI) using the oligonuc-
leotides 50-ACAGGCGCGCCAGTCCTCCGATTGACTGA-
GTCGCCCGGGTACCGCGG and 50-TCAGCGGCCGCAT-
GATCTTAATTAACGGGCCCGCGGTACCCGGGCGAC.
Oligo-(dT) primers with a NotI restriction site were used to
synthesize ﬁrst strand cDNA, afterwards an adaptor oligo-
nucleotide containing MluI was ligated to the double-
stranded cDNA. Following digestion with NotI and MluI
restriction enzymes, the cDNA was size-fractionated by
column chromatography to remove small cDNA fragments,
making the cloning of larger inserts more probable. Only the
middle and large size fraction of cDNA (>200 bp) were
ligated in antisense direction into the retroviral vector
under control of the SFFV promotor. Ligation products
were electrotransformed into XL1-Blue competent cells
(Stratagene, Heidelberg, Germany). Colonies from Luria–
Bertani agar plates were scraped and pooled; plasmid DNA
from primary library was directly extracted with Maxi prep.
(MACHEREY-NAGEL, Du ¨ren, Germany) without further
ampliﬁcation.
Retrovirus production and transduction of Saos-2 cells
To package the retroviral antisense library, 5 mg plasmid DNA
from the primary cDNA library and 5 mg of the envelope
plasmids containing VSV-G (28) or RD114 (29) were trans-
fected per 10 cm plate of HEK293T cells using 30 ml
FuGENE-6 transfection reagent (Roche, Mannheim,
Germany). Forty-eight hours later, retroviruses containing
supernatants were harvested fresh, ﬁltered through 0.45 mm
and used to infect Saos-2ERE2F1 cells in the presence of
10 mg/ml protamine (Sigma). The gene transfer efﬁciency
of the EGFP expressing VSV-G or RD114 pseudotyped
control plasmid into Saos-2ERE2F1 cells was 66 and 59%,
respectively, as analysed by ﬂow cytometry on a Becton
Dickinson FACSCalibur (Heidelberg, Germany; data not
shown). To achieve integration of a single copy of retroviral
library vector in the genome, the fresh supernatant was diluted
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1 mM 4-OHT was added. Cells were cultured in 4-OHT con-
tinuously for more than 4 weeks. Thereafter, surviving cells
formed single cell clones, which were individually picked and
expanded. From these clones, genomic DNA was extracted
(Peq lab, Erlangen, Germany) and used as template to char-
acterize integrated genes.
Nested PCR
Analiquotof100–200nggenomicDNAwasutilizedtoperform
nested PCR to identify integrated genes. The following two
primer sets were chosen from the retrovirus vector sequence
ﬂanking inserts: outer primers, AGATATGGCCCAACCCT-
CAGCAGT(sense)andCTACAGGTGGGGTCTTTCATTCC
(antisense); inner primers, TCGCGCGCTTCTGCTTCCCG
(sense) and TGGCTGTACTCTATAGGCT (antisense). For
theﬁrstPCR,thefollowingparameterswereused:ﬁrst10cycles,
annealing temperature was decreased in 0.5 C each cycle from
66 C, followed by 25 cycles at constant annealing temperature
of 61 C. PCR products were puriﬁed with PCR puriﬁcation
system (MARLIGEN Bioscience, Heidelberg, Germany) and
used as templates for a second PCR under the same conditions
over25cycles.Reactionproductswereloadedonto1%agarose
gel,andcorrespondingbandswerecutfromgelsandsubcloned
into the pcDNA3.1 V5-His topo vector. cDNA inserts were
identiﬁed by sequencing (Seqlab, Go ¨ttingen, Germany).
Flow cytometry and XTT assay
Cell lines were grown under starvation conditions with 1%
BSA for 24 h before 4-OHT was added at a ﬁnal concentration
of1mM.Cellswereharvestedatindicatedtimesafterinfection,
ﬁxed in 70% ethanol and stained for DNA content with prop-
idium iodide. Flow cytometric analysis was carried out in a
FACSCalibur ﬂow cytometer (Becton Dickinson, San Diego,
CA) using CellQuest software. For XTT assay, cells were
seededon96-wellplatesandstarvedfor24hin1%BSAbefore
4-OHT was added at different time points post-induction.
TACS XTTcellproliferationassaywasperformedaccording
to the manual (Trevigen Inc., Gaithersburg, MD).
Western blot analysis
Cells were lysed in RIPA buffer [50 mM Tris–HCl, pH 7.2,
150 mM NaCl, 1% Triton X-100 (v/v), 1% Na-Deoxycholate
(v/v) and 0.1% SDS (w/v)] and total protein concentration was
quantitated by Bradford assay (Biorad). Samples (100 mg per
lane) were separated by SDS–PAGE, transferred to nitrocel-
lulose membranes (Amersham Pharmacia Biotech) andprobed
with antibodies against actinin a-4 (CHEMICON), melanoma
cell adhesion molecule (MCAM) (R&D systems) and small
nuclear ribonucleoprotein E (SNRPE) from Santa Cruz Bio-
technology (Heidelberg, Germany) according to the manufac-
turers’ guidelines. Primary antibodies were detected using the
Figure 1. TKO selection. (A) Schematic representation of retroviral vector pczCAMS/U3E based on MuLV. The antisense cDNA expression library was ligated
into the NotI and MluI restriction sites downstream of the SFFV promoter. (B) The strategy is based on random inactivation of genes after retroviral transfer of an
antisense cDNA library enriched of E2F1-induced genes, followed by the selection of Saos-2ERE2F1 cells that survive in the presence of the apoptotic stimulus.
TheantisensecDNAlibrarywascotransfectedwithRD114orVSV-GintoHEK293Tcellstogenerateretrovirus.CellsupernatantwasusedtoinfectSaos-2ERE2F1
cells followed by the addition of 4-OHT. DNA was extracted from growing clones and analysed for integrated genes by PCR.
Nucleic Acids Research, 2005, Vol. 33, No. 9 2815appropriate secondary antibody-horseradish peroxidase con-
jugate (Amersham Pharmacia, Braunschweig, Germany).
Real-time RT–PCR analysis
Total RNA was extracted with the RNeasy Mini Kit (Qiagen)
according to the manufacturer’s protocol and 1 mg RNA was
reverse transcribed using Omniscript RT (Qiagen) and Oligo-
(dT) primer. The cDNA sample was diluted 1:5. Taqman
quantitative PCR was performed using 250 ng cDNA sample,
20· reaction mixture and 2· TaqMan Universal PCR Master
Mix (Applied Biosystems, Darmstadt, Germany) according
to the manufacturer’s instruction, in conjunction with ABI
PRISM 7700 HT Sequence Detection Systems. Gene expres-
sion proﬁle was achieved using the comparative CT method of
relative quantiﬁcation (GAPDH as the endogenous control).
Statistical analysis
Statistical signiﬁcance was calculated by paired Student’s
t test. All statistical tests are two-sided.
RESULTS
EstablishmentofSaos-2ERE2F1celllinesthatsurvivein
the presence of activated E2F1
A prerequisite for the success of the functional so-called TKO
strategy (21) is the stable transduction of a large number of
cells with a vector that expresses high levels of an antisense
cDNA library in the continuous presence of activated E2F1
and that can be easily rescued from the stable clones. In con-
trast to the original TKO system, we chose a self-inactivating
oncoretroviral vector system for the delivery of the cDNA
library into Saos-2ERE2F1 cells, as oncoretroviruses can efﬁ-
ciently transduce human cell lines usually with oligoclonal
integration pattern per cell (28). For high level expression
of antisense mRNA transcripts, double-stranded cDNA frag-
ments were ligated in antisense direction into the modiﬁed
oncoretroviralplasmidunderthecontroloftheSFFVpromoter
(Figure1A),which hasbeenusedbyusandothers forthelong-
term expression of transgenes in mammalian cells (30). To test
the quality of the cDNA library, plasmid DNA from 11 ran-
domly picked clones was extracted and PCR was performed
using primers ﬂanking the integration sites. Nine of the eleven
clones contained inserts of different size (cloning efﬁciency of
80%). The library consists of 5 · 10
6 independent clones per
1 mg vector. VSV-G or RD114-pseudotyped retrovirus vector
expressing the antisense cDNA library was rescued from the
supernatant of HEK293T cells and used to infect Saos-
2ERE2F1 cells. After 4 weeks, single cell clones that survived
under continuous activation of E2F1 were picked, genomic
DNA was extracted and the antisense cDNAs were rescued
(Figure 1B).
Identification of antisense cDNA inserts
The cDNA inserts contained in the vector that reduced the
susceptibility of the clones to E2F1-induced cell death were
rescued by PCR. We found 13 cDNA inserts of a size ranging
from 300 to 900 bp (Table 1). Sequence analysis revealed that
12 inserts match to genes encoding proteins of known cellular
function, including apoptosis (ACTN4, ATP5J, LGAS1 and
UBB), RNA-binding (RNPC7, RPL8 and RPL32) and pre-
mRNA splicing (SNRPE). For example, Ubiquitin B (UBB)
was shown to be involved in apoptosis via different mechan-
isms and is required for the degradation of several pro-
apoptotic proteins (31,32). The nucleotide sequence of one
cDNA was unknown. Eleven cDNA clones were identiﬁed
as fragments and two appeared to be full-length (Table 1
and Figure 2). The antisense orientation of the cDNA was
veriﬁed by both restriction and sequence analysis.
Antisense cDNAs rescued from Saos-2ERE2F1 clones
in the presence of activated E2F1 confer apoptosis
resistance
Previous reports have demonstrated that the TKO strategy is a
very efﬁcient method to select for positive mediators of cell
death (21). We next performed functional assays to determine
whether the isolated antisense fragments could individually
convert Saos-2ERE2F1 cells from E2F1 death sensitivity to
E2F1 death resistance. In cell clones containing antisense
cDNA fragmentsof three identiﬁed genes, THEM2(clone R3),
RNPC7 (clone R40) and ATP5J (clone R7), E2F1 was stimu-
lated by 4-OHT treatment and the sub-G1 DNA content, indic-
ative for apoptosis, was measured by ﬂow cytometry. As
shown in Figure 3, selective inhibition of these genes resulted
in a clear decrease of apoptotic cells (increased resistance
against E2F1-mediated cell death) at 32 h after induction
[between 12% (R7), 23% (R3) and 29% (R40)] compared
with stimulated Saos-2ERE2F1 control cells that do not
Table 1. Genes identified by the TKO selection approach
Accession number Gene name cDNA Identified Locus Frequency Function
BC007442 ACTG1 1938 900 17q25 5 Actin G
NM_004924 ACTN4 3893 580 19q13 6 Actinin alpha-4
NM_001003703 ATP5J 1303 540 19q13.2 10 ATP synthase, mitochondrial F0 complex, subunit F6
NM_002305 LGAS1 526 363 22q13.1 3 Lectin, galactoside-binding, soluble, 1 (galectin 1)
NM_006500 MCAM 3583 663 11q23.3 1 Melanoma cell adhesion molecule
BC062440 RNPC7 1087 510 14q24.3 1 RNA-binding motif protein 25
BC000077 RPL8 892 525 8q24.3 1 Ribosomal protein L8
NM_000994 RPL32 521 Full-length 3q25–p24 2 Ribosomal protein L32
NM_006280 SSR4 642 360 Xq28 11 Signal sequence receptor, delta
BC000894 THEM2 616 390 6p22.2 17 Thioesterase superfamily member 2
BC009301 UBB 943 820 17p12–p11.2 2 Ubiquitin B
M37716 SNRPE 491 Full-length 1q25–q43 5 Small nuclear RNA protein E
n.a. Unknown n.a. 480 5q33.2 1 n.a.
2816 Nucleic Acids Research, 2005, Vol. 33, No. 9express antisense cDNA fragments (46%). These data suggest
that the rescued genes are positive regulators of E2F1-induced
apoptosis. Similar results were obtained from cell viability
assays shown in Figure 4. We observed a substantial increase
of cell viability (>70%) in response to E2F1 activation in those
cells lines containing antisense fragments of the genes LGAS1
(clone V5), MCAM (clone V25), ATP5J (clone R7), RPL32
(cloneV50),RPL8(cloneV27)andSNRPE(cloneR60)at72h
after induction, whereas only 30% of the control cells lacking
antisense fragments survived (Figure 4A). To conﬁrm that the
observed phenotype is due to the gene product corresponding
to the antisense cDNA, expression plasmids encoding LGAS1,
SNRPE and ATP5J antisense fragments were transfected into
parental Saos2-ERE2F1 cells. Consistent with the data shown
in Figure 4A, ectopic expression of the antisense fragments
resulted in a signiﬁcantly increased cell viability (>40%) com-
pared with the untransfected control (<25%) at 72 h after E2F1
stimulation (Figure 4B).
Furthermore, changes in the expression of the identiﬁed
genes in response to E2F1 activation were analysed on protein
level. Compared with the expression of, for example, actinin
a-4, MCAM and SNRPE in parental Saos-2ERE2F1 cells, cell
clones containing the antisense cDNA fragments revealed sig-
niﬁcantly lower protein levels (Figure 5). These date support
the notion that the increased growth advantage of antisense
containing cells is acquired owing to the inhibition of E2F1
target gene expression by the antisense cDNA.
Expression profiles of identified genes in response to
E2F1 stimulation
As an advantage of the ERE2F1 regulatory system, it enables
us to measure the effect of E2F1 activation in the absence of
de novo protein synthesis, thus allowing the identiﬁcation of
directly activated transcripts (25,33). To correlate changes in
the expression of genes corresponding to the identiﬁed anti-
sense cDNAs with E2F1 activation, a subset of genes (LGAS1,
ACTN4, MCAM, SSR4 and UBB) was further analysed in the
presence of cycloheximide (CHX). By the addition of 4-OHT,
a signiﬁcant increase in the expression intensity was observed
for all candidate genes between 8 and 24 h. The genes ACTN4,
LGAS1, MCAM and SSR4 were also signiﬁcantly upregulated
in the presence of CHX (ACTN4, LGAS1, SSR4 <3-fold;
MCAM >100-fold at 16 h), suggesting that they are directly
transactivated by E2F1. In contrast, upregulation of UBB, for
example, found with 4-OHT alone, could not be observed
following the addition of CHX (Figure 6). This result indicates
that UBB upregulation in response to E2F1 might not be a
direct effect. However, since we observed an only moderate
increase of LGAS1, SSR4, and UBB in response to the ectopic
expression of E2F1, additional experiments are required to
unambiguously consider these genes as direct or indirect
E2F1 targets.
DISCUSSION
The importance of the E2F1 transcription factor for the induc-
tion of apoptosis either in association with p53 or alone is
Figure 2. Identificationofintegratedgenes.Atotalof13geneswereidentifiedfromindicatedclonesbyNCBIhumangenomicDNAdatabasesearch(V = VSV-G;
R = RD114).
Figure 3. Apoptosis resistance of cell clones containing antisense cDNA frag-
ments. Saos-2ERE2F1 cells were treated with 4-OHT and analysed by flow
cytometry at indicated time points. Saos2-ERE2F1 cells transfected with a
plasmid expressing antisense against p73 (p73-AS) or GFP (GFP-AS) were
used as a positive and negative control, respectively. The percentage of cells
with a sub-G1 DNA content is as shown (Saos-2ERE2F, black rhombus;
Saos2-ERE2F1plusGFP-AS,greyrhombus;cloneR3_THEM2,blacktriangle;
clone R7_ATP5J, circle; clone R40_RNPC7, black square; Saos2-ERE2F1
plus p73-AS, grey square). Each graph represents the mean – SD of three
independent experiments.
Nucleic Acids Research, 2005, Vol. 33, No. 9 2817evident by a large number of studies. Most of them suggest
that E2F1 controls apoptosis through an indirect mechanism
by transcriptional activation of downstream factors, which in
turnproducesecondary changesin gene expressionthat trigger
apoptosis (12,17,18). Although the complete mechanism by
which E2F1 induces apoptosis is still not understood, it
becomes clear from these studies that E2F1 is involved in
many aspects of programmed cell death. In this work, we
demonstrate that, consistent with other previous reports
(21–24), applying the functional approach of antisense knock-
out is a successful strategy for the isolation of novel genes that
function as positive mediators of cell death. A growth advant-
age, conferred by the expression of antisense RNA, serves as a
strong positive selection method in an environment restricted
to the presence of activated E2F1.
In our study, we identiﬁed 12 known genes that are involved
in E2F1-induced cell death pathways. Some of these genes
have been demonstrated to mediate apoptosis in various cell
systems. For example, galectin 1 (LGAS1) induced apoptosis
in T cell (34) and some other cell lines (35). Actinin a-4
(ACTN4) was shown to directly interact with DNase Y and to
stabilize its endonuclease activity during apoptosis (36),
whereas overexpression of DNase Y alone cannot induce
apoptosis. Based on our data, actinin a-4 is directly upregu-
lated by E2F1. Moreover, two ribosomal proteins (RPL32 and
RPL8) were identiﬁed in this study that belong to a protein
familyinwhichothermembershavebeenshowntoberespons-
ible for cell cycle arrest or apoptosis (37–39) in human and
mouse cell lines, and to sensitize them for chemotherapy.
However,incontrasttoourpreviouscDNAmicroarray analysis
Figure 4. Analysis of cell survival by XTT assay. Cell viability was assayed every 24 h over a period of 3 days after E2F1 activation by 4-OHT. The percentage of
viablecells(A)fromcloneV5(LGAS1),cloneV25(MCAM),cloneR7(ATP5J),cloneV50(RPL32),cloneV27(RPL8)andcloneR60(SNRPE)areshowninrelation
to parental Saos-2ERE2F1 cells and (B) from Saos-2ERE2F1 cells transfected with 10 mg expression plasmid encoding for LGAS1, SNRPE and ATP5J compared
withuntransfectedcellsorcellstransfectedwithGFP-ASplasmid.Thep73-ASexpressionplasmidwasusedaspositivecontrol.Datawereobtainedfromthreevials
per time point measured in duplicate. SD is indicated by error bars; 24 h, black bar; 48 h, grey bar; 72 h, white bar.
2818 Nucleic Acids Research, 2005, Vol. 33, No. 9(25), none of the positive hits is a well-known component of
the apoptotic machinery or an established pro-apoptotic tar-
get of E2F1. This is likely due to the fact that the functional
TKO approach largely depends on the abundance of antisense
cDNA in the library and on its inhibitory efﬁciency. Because
of the lack of a full inhibition of the corresponding genes by
the antisense cDNA, the functional approach might not pull
out major apoptosis inducers.
We analysed apoptosis in a representative choice of cell
clones containing the identiﬁed antisense gene fragments
by measuring the sub-G1 DNA content. Following E2F1
activation, all cell lines showed a clear resistance against
E2F1-mediated apoptosis compared with parental Saos-
2ERE2F1. Clone R7, for example, containing the antisense
cDNA of the F6 subunit from the ATP synthase F0 sector
(ATP5J), exhibited the lowest apoptotic rate in response to
activated E2F1. The proton–ATP synthase complex is located
in the inner mitochondrial membrane where it couples the
electrochemical potential gradient generated by the oxidore-
duction reactions of the enzyme complexes of the electron
transport chain to the synthesis of ATP from ADP and Pi
(40). The F0 sector is the membrane sector and is involved
in proton translocation. It has previously been shown that the
inhibition of ATP synthase suppresses TNF-induced apoptosis
in HeLa cells (41). Our data suggest that the mitochondrial
ATP synthase might also be involved in the E2F1 death path-
way, although the mechanism is unclear. Thus, together with
previously published data indicating a direct modulation of the
human cytochrome c1 promoter (42), and upregulation of the
apoptosis-inducing factor in the cytosol and the recently iden-
tiﬁed mitochondrial death-inducing protein DIP by E2F1 (43),
our results support that E2F1 triggers apoptosis by stimulating
death-related factors in the mitochondrion.
The same conclusions can be made from the XTT cytotox-
icity assay in cells containing the antisense gene fragment of
ATP5J. Expression of the antisense cDNA clearly protected
them from cell death, as judged by an  60% (at 72 h)
enhanced viability in the continuous presence of activated
E2F1. Consistent with its role as a promoter of cellular apop-
tosis, an even better protection against E2F1-induced cell
death (>80%) was observed through the inhibition of
galectin-1 (LGAS1). Galectin-1 has been shown to induce
Figure6. ClassificationofE2F1targetgenesasdirectandindirect.Geneexpressionwasanalysedinserum-starvedSaos-2ERE2F1cellscontainingantisensecDNA
inthepresenceof4-OHT(darkgreybars)and/orCHX(greybars)afterinfectionwithAd-ERE2F1byquantitativeRT–PCR.Alltargetsareshownat0,8,16and24h
after induction. Bars show the copy number ·100 000 (·1000 for MCAM) after normalization for GAPDH as a housekeeping gene. Significant differences
(P < 0.05;paired,two-sidedt-test)between4-OHTand4-OHTplusCHX-treatedcellsarelabelledwithasterisk.ACTN4,LGAS1,MCAMandSSR4aredirecttargets,
whereas UBB is an indirect target.
Figure 5. Verification of the gene expression profile on protein level. Serum-
starved parental Saos-2ERE2F1 cells and Saos-2ERE2F1 cell clones contain-
ing the antisense cDNA fragment of actinin a-4, MCAM and SNRPE were
induced by the addition of 4-OHT. At indicated time points, equal amounts of
whole-cell extracts were assayed for actinin-a4, MCAM and SNRPE protein.
GAPDH was used as a loading control.
Nucleic Acids Research, 2005, Vol. 33, No. 9 2819apoptosis of macrophages, thymocytes, T and B cells (44).
Pircher and co-workers (45) detected an increase in galectin-1
synthesis after the activation of murine T cells and suggested
that galectin-1 may act in an autocrine negative regulatory
system to terminate an immune response by killing T cells.
In that context, it was demonstrated that E2F1 is required for
the apoptosis of autoimmune immature T cells during thymic
negative selection in vivo (46,47). These results implicate a
speciﬁc role for galectin-1 in E2F1-mediated T cell apoptosis
in the absence of p53.
Applying the method of functional selection has resulted in
the identiﬁcation of genes with a wide spectrum of cellular
functions. Actin G (ACTG1) and actinin a-4 (ACTN4), for
example, are cytoskeleton proteins; RPL32 and RPL8 belong
to the group of ribosomal proteins. ATP5J is a component of
ATP synthase localized in the mitochondria and sequence
receptor delta (SSR4) is involved in the secretion of proteins.
As the most interesting ﬁnding of this screening approach, we
identiﬁed two genes, RNPC-7 and the SNRPE, one common
component of all spliceosomal snRNP core complexes in
the nucleus of eukaryotic cells (48). These proteins harbour
a RNA-binding motif and participate in pre-mRNA splicing,
suggesting that RNA splicing is crucial for mediating E2F1-
induced apoptosis. A potential role for alternative splicing in
apoptosis was suggested by the discovery of functionally act-
ive alternatively spliced variants of major apoptosis regulators
(49), such as Bcl-x, Ich-1, caspase-9, Apaf-1 and Tid1
(50–52). In all cases, the alternatively spliced isoforms play
an opposing role in apoptosis. For example, the long isoform
of Bcl-x (Bcl-Xl) and Ced-4 protect cells against apoptosis,
whereas their short isoform (Bcl-Xs) and Cde-4S, respect-
ively, promote cell death. On the other hand, the long isoform
of Ich-1 (Ich-1L) induces apoptosis, whereas the short isoform
(Ich-1S) inhibitsit. Pre-mRNAsplicingis avery sophisticated,
partially known process, in which over 100 proteins are
involved. A potential link between pre-mRNA splicing and
E2F1-induced cell death and the underlying mechanism
remains to be elucidated.
There is increasing evidence that E2F1 induces p53-
independent apoptosis via different cellular pathways,
including a variety of pro-apoptotic factors, supporting its
role as a key player in an anti-tumour safeguard mechanism.
Because of a potential functional redundancy of pro-
apoptotic E2F1 targets, it might be possible that some genes
are not identiﬁed by this approach. Although this study iden-
tiﬁed several novel E2F1 target genes, which are surely
involved in several different pathways, the role of each
gene for E2F1-induced cell death remains speculative until
further experimental data have been gathered. Of particular
interest is the fact that single factors from multifactor com-
plexes, such as ATP synthase or SNRPE, seem to play a role
in apoptosis induction even though other components of
these complexes could not be identiﬁed in our screen. There-
fore, it can be anticipated that different complex composi-
tions carry out different functions in distinct cellular
contexts. Furthermore, one gene, the MCAM, with a very
strong response to E2F1 stimulation but without any cur-
rently known relation to apoptosis induction has been iden-
tiﬁed here. Consequently, follow-up studies analyzing each
target gene in detail have to be awaited to further classify
particular novel E2F1-regulated genes.
ACKNOWLEDGEMENTS
The authors thank Carmen Theseling and Anja Stoll for excel-
lent technical assistance. This work was supported by grant
10-1934-Pu ¨3 from the Deutsche Krebshilfe to B.M.P. Funding
to pay the Open Access publication charges for this article was
provided by the University of Rostock.
Conflict of interest statement. None declared.
REFERENCES
1. DeGregori,J. (2002) The genetics of the E2F family of transcription
factors: shared functions and unique roles. Biochim. Biophys. Acta,
1602, 131–150.
2. Ginsberg,D. (2002) E2F1 pathways to apoptosis. FEBS Lett., 529,
122–125.
3. Kowalik,T.F., DeGregori,J., Schwarz,J.K. and Nevins,J.R. (1995) E2F1
overexpression in quiescent fibroblasts leads to induction of cellular
DNA synthesis and apoptosis. J. Virol., 69, 2491–2500.
4. Muller,H., Bracken,A.P., Vernell,R., Moroni,M.C., Christians,F.,
Grassilli,E.,Prosperini,E.,Vigo,E.,Oliner,J.D.andHelin,K.(2001)E2Fs
regulatetheexpressionofgenesinvolvedindifferentiation,development,
proliferation and apoptosis. Genes Dev., 15, 267–285.
5. Dyson,N. (1998) The regulation of E2F by pRB-family proteins.
Genes Dev., 12, 2245–2262.
6. Stevaux,O. and Dyson,N.J. (2002) A revised picture of the E2F
transcriptional network and RB function. Curr. Opin. Cell Biol., 14,
684–691.
7. Lin,W.C., Lin,F.T. and Nevins,J.R. (2001) Selective induction of E2F1
in response to DNA damage, mediated by ATM-dependent
phosphorylation. Genes Dev., 15, 1833–1844.
8. Stevens,C., Smith,L. and La Thangue,N.B. (2003) Chk2 activates E2F-1
in response to DNA damage. Nature Cell Biol., 5, 401–409.
9. Powers,J.T., Hong,S., Mayhew,C.N., Rogers,P.M., Knudsen,E.S. and
Johnson,D.G. (2004) E2F1 uses the ATM signaling pathway to induce
p53 and Chk2 phosphorylation and apoptosis. Mol. Cancer Res., 2,
203–214.
10. Ianari,A., Gallo,R., Palma,M., Alesse,E. and Gulino,A. (2004) Specific
role for p300/CREB-binding protein-associated factor activity in E2F1
stabilization in response to DNA damage. J. Biol. Chem., 279,
30830–30835.
11. Hiebert,S.W., Packham,G., Strom,D.K., Haffner,R., Oren,M.,
Zambetti,G. and Cleveland,J.L. (1995) E2F-1:DP-1 induces p53 and
overrides survival factors to trigger apoptosis. Mol. Cell. Biol., 15,
6864–6874.
12. Bates,S., Phillips,A.C., Clark,P.A., Stott,F., Peters,G., Ludwig,R.L. and
Vousden,K.H. (1998) p14ARF links the tumour suppressors RB and
p53. Nature, 395, 124–125.
13. Robertson,K.D. and Jones,P.A. (1998) The human ARF cell cycle
regulatory gene promoter is a CpG island which can be silenced by DNA
methylation and down-regulated by wild-type p53. Mol. Cell. Biol., 18,
6457–6473.
14. Rogoff,H.A., Pickering,M.T., Debatis,M.E., Jones,S. and
Kowalik,T.F. (2002) E2F1 induces phosphorylation of p53 that is
coincident with p53 accumulation and apoptosis. Mol. Cell. Biol., 22,
5308–5318.
15. Russell,J.L., Powers,J.T., Rounbehler,R.J., Rogers,P.M., Conti,C.J. and
Johnson,D.G. (2002) ARF differentially modulates apoptosis induced
by E2F1 and Myc. Mol. Cell. Biol., 22, 1360–1368.
16. Tsai,K.Y., MacPherson,D., Rubinson,D.A., Crowley,D. and Jacks,T.
(2002) ARF is not required for apoptosis in Rb mutant mouse embryos.
Curr. Biol., 12, 159–163.
17. Irwin,M., Marin,M.C., Phillips,A.C., Seelan,R.S., Smith,D.I., Liu,W.,
Flores,E.R., Tsai,K.Y., Jacks,T., Vousden,K.H. et al. (2000) Role for the
p53 homologue p73 in E2F-1-induced apoptosis. Nature, 407,
645–648.
18. Stiewe,T. and Putzer,B.M. (2000) Role of the p53-homologue p73 in
E2F1-induced apoptosis. Nature Genet., 26, 464–469.
19. Furukawa,Y., Nishimura,N., Satoh,M., Endo,H., Iwase,S., Yamada,H.,
Matsuda,M., Kano,Y. and Nakamura,M. (2002) Apaf-1 is a mediator of
E2F-1-induced apoptosis. J. Biol. Chem., 277, 39760–39768.
2820 Nucleic Acids Research, 2005, Vol. 33, No. 920. Hershko,T. and Ginsberg,D. (2004) Up-regulation of Bcl-2 homology 3
(BH3)-only proteins by E2F1 mediates apoptosis. J. Biol. Chem., 279,
8627–8634.
21. Deiss,L.P. and Kimchi,A. (1991) A genetic tool used to identify
thioredoxin as a mediator of a growth inhibitory signal. Science,
252, 117–120.
22. Deiss,L.P., Galinka,H., Berissi,H., Cohen,O. and Kimchi,A. (1996)
Cathepsin D protease mediates programmed cell death induced by
interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J., 15,
3861–3870.
23. Deiss,L.P., Feinstein,E., Berissi,H., Cohen,O. and Kimchi,A. (1995)
Identification of a novel serine/threonine kinase and a novel 15-kD
protein as potential mediators of the gamma interferon-induced cell
death. Genes Dev., 9, 15–30.
24. Kissil,J.L., Deiss,L.P., Bayewitch,M., Raveh,T., Khaspekov,G. and
Kimchi,A. (1995) Isolation of DAP3, a novel mediator of
interferon-gamma-inducedcelldeath.J.Biol.Chem.,270,27932–27936.
25. Stanelle,J., Stiewe,T., Theseling,C.C., Peter,M. and Putzer,B.M.
(2002) Gene expression changes in response to E2F1 activation.
Nucleic Acids Res., 30, 1859–1867.
26. Putzer,B.M., Stiewe,T., Crespo,F. and Esche,H. (2000) Improved
safety through tamoxifen-regulated induction of cytotoxic genes
delivered by Ad vectors for cancer gene therapy. Gene Ther., 7,
1317–1325.
27. Stanelle,J., Stiewe,T., Rodicker,F., Kohler,K., Theseling,C. and
Putzer,B.M. (2003) Mechanism of E2F1-induced apoptosis in primary
vascular smooth muscle cells. Cardiovasc. Res., 59, 512–519.
28. Leurs,C., Jansen,M., Pollok,K.E., Heinkelein,M., Schmidt,M.,
Wissler,M., Lindemann,D., Von Kalle,C., Rethwilm,A., Williams,D.A.
et al. (2003) Comparison of three retroviral vector systems for
transduction of nonobese diabetic/severe combined immunodeficiency
mice repopulating human CD34+ cord blood cells. Hum. Gene Ther.,
14, 509–519.
29. Sandrin,V., Boson,B., Salmon,P., Gay,W., Negre,D., Le Grand,R.,
Trono,D. and Cosset,F.L. (2002) Lentiviral vectors pseudotyped with a
modified RD114 envelope glycoprotein show increased stability in sera
and augmented transduction of primary lymphocytes and CD34+ cells
derived from human and nonhuman primates. Blood, 100, 823–832.
30. Baum,C., Hegewisch-Becker,S., Eckert,H.G., Stocking,C. and
Ostertag,W. (1995) Novel retroviral vectors for efficient expression
of the multidrug resistance (mdr-1) gene in early hematopoietic cells.
J. Virol., 69, 7541–7547.
31. Bernassola,F., Salomoni,P., Oberst,A., Di Como,C.J., Pagano,M.,
Melino,G. and Pandolfi,P.P. (2004) Ubiquitin-dependent degradation
of p73 is inhibited by PML. J. Exp. Med., 199, 1545–1557.
32. Zhang,H.G., Wang,J., Yang,X., Hsu,H.C. and Mountz,J.D. (2004)
Regulation of apoptosis proteins in cancer cells by ubiquitin.
Oncogene, 23, 2009–2015.
33. Helin,K. (1998) Regulation of cell proliferation by the E2F transcription
factors. Curr. Opin. Genet. Dev., 8, 28–35.
34. Perillo,N.L., Pace,K.E., Seilhamer,J.J. and Baum,L.G. (1995) Apoptosis
of T cells mediated by galectin-1. Nature, 378, 736–739.
35. Horiguchi,N., Arimoto,K., Mizutani,A., Endo-Ichikawa,Y., Nakada,H.
and Taketani,S. (2003) Galectin-1 induces cell adhesion to the
extracellular matrix and apoptosis of non-adherent human colon
cancer Colo201 cells. J. Biochem., 134, 869–874.
36. Liu,Q.Y., Lei,J.X., LeBlanc,J., Sodja,C., Ly,D., Charlebois,C.,
Walker,P.R., Yamada,T., Hirohashi,S. and Sikorska,M. (2004)
Regulation of DNaseY activity by actinin-alpha4 during apoptosis.
Cell Death Differ., 11, 645–654.
37. Khanna,N.,Sen,S.,Sharma,H.andSingh,N.(2003)S29ribosomalprotein
induces apoptosis in H520 cells and sensitizes them to chemotherapy.
Biochem. Biophys. Res. Commun., 304, 26–35.
38. Nishiura,H., Tanase,S., Shibuya,Y., Futa,N., Sakamoto,T.,
Higginbottom,A., Monk,P., Zwirner,J. and Yamamoto,T. (2004) S19
ribosomal protein dimer augments metal-induced apoptosis in a mouse
fibroblastic cell line by ligation of the C5a receptor. J. Cell. Biochem.,
94, 540–553.
39. Shi,Y., Zhai,H., Wang,X., Han,Z., Liu,C., Lan,M., Du,J., Guo,C.,
Zhang,Y., Wu,K. et al. (2004) Ribosomal proteins S13 and L23 promote
multidrug resistance in gastric cancer cells by suppressing drug-induced
apoptosis. Exp. Cell Res., 296, 337–346.
40. Breen,G.A., Miller,D.L., Holmans,P.L. and Welch,G. (1986)
Mitochondrial DNA of two independent oligomycin-resistant Chinese
hamster ovary cell lines contains a single nucleotide change in the
ATPase 6 gene. J. Biol. Chem., 261, 11680–11685.
41. Shchepina,L.A., Pletjushkina,O.Y., Avetisyan,A.V., Bakeeva,L.E.,
Fetisova,E.K., Izyumov,D.S., Saprunova,V.B., Vyssokikh,M.Y.,
Chernyak,B.V. and Skulachev,V.P. (2002) Oligomycin, inhibitor of the
F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis.
Oncogene, 21, 8149–8157.
42. Luciakova,K., Barath,P., Li,R., Zaid,A. and Nelson,B.D. (2000)
Activity of the human cytochrome c1 promoter is modulated by E2F.
Biochem. J., 351, 251–256.
43. Vorburger,S.A., Pataer,A., Yoshida,K., Liu,Y., Lu,X., Swisher,S.G. and
Hunt,K.K. (2003) The mitochondrial apoptosis-inducing factor plays a
role in E2F-1-induced apoptosis in human colon cancer cells. Ann. Surg.
Oncol., 10, 314–322.
44. Hernandez,J.D. and Baum,L.G. (2002) Ah, sweet mystery of death!
Galectins and control of cell fate. Glycobiology, 12, 127R–136R.
45. Blaser,C., Kaufmann,M., Muller,C., Zimmermann,C., Wells,V.,
Mallucci,L. and Pircher,H. (1998) Beta-galactoside-binding protein
secreted by activated T cells inhibits antigen-induced proliferation of
T cells. Eur. J. Immunol., 28, 2311–2319.
46. Garcia,I., Murga,M., Vicario,A., Field,S.J. and Zubiaga,A.M. (2000)
A role for E2F1 in the induction of apoptosis during thymic negative
selection. Cell Growth Differ., 11, 91–98.
47. Zhu,J.W., DeRyckere,D., Li,F.X., Wan,Y.Y. and DeGregori,J. (1999)
A role for E2F1 in the induction of ARF, p53, and apoptosis during
thymic negative selection. Cell Growth Differ., 10, 829–838.
48. Luhrmann,R., Kastner,B. and Bach,M. (1990) Structure of spliceosomal
snRNPs and their role in pre-mRNA splicing. Biochim. Biophys. Acta,
1087, 265–292.
49. Wu,J.Y., Tang,H. and Havlioglu,N. (2003) Alternative pre-mRNA
splicing and regulation of programmed cell death. Prog. Mol. Subcell.
Biol., 31, 153–185.
50. Bae,J., Leo,C.P., Hsu,S.Y. and Hsueh,A.J. (2000) MCL-1S, a splicing
variant of the antiapoptotic BCL-2 family member MCL-1, encodes a
proapoptotic protein possessing only the BH3 domain. J. Biol. Chem.,
275, 25255–25261.
51. Fu,W.N., Kelsey,S.M., Newland,A.C. and Jia,L. (2001) Apaf-1XL is an
inactive isoform compared with Apaf-1L. Biochem. Biophys. Res.
Commun., 282, 268–272.
52. Syken,J., De-Medina,T. and Munger,K. (1999) TID1, a human homolog
of the Drosophila tumor suppressor l(2)tid, encodes two mitochondrial
modulators of apoptosis with opposing functions. Proc. Natl Acad. Sci.
USA, 96, 8499–8504.
Nucleic Acids Research, 2005, Vol. 33, No. 9 2821